Showing results (221-230 of 757) with videos related to

Sort By:
Pageof 76
Open Heart|January 12, 2025
Automated electronic health record-based screening for Fabry disease in unexplained left ventricular hypertrophy (FAPREV-HCM)Kolja Lau, Victoria Sokalski, Lora Lorenz, et al.
Endocrinology, Diabetes & Metabolism|December 27, 2022
Potassium management with finerenone: Practical aspectsChristoph Wanner, Paola Fioretto, Csaba P Kovesdy, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyAndreas Schneider, Christiane Drechsler, Vera Krane, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 8, 2017
Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patientsBruce E Reidenberg, Christoph Wanner, Bruce Polsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 16, 2010
Changes in parathyroid hormone, body mass index and the association with mortality in dialysis patientsChristiane Drechsler, Diana C Grootendorst, Elisabeth W Boeschoten, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2010
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapyDetlef H Krieter, Regina Fischer, Karin Merget, et al.
The American Journal of Cardiology|July 31, 2014
Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry diseaseJohannes Krämer, Markus Niemann, Stefan Störk, et al.
JIMD Reports|February 23, 2013
Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry DiseaseMarkus Niemann, Arndt Rolfs, Anne Giese, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 30, 2013
Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)Fabian Hammer, Vera Krane, Stefan Störk, et al.
Journal of Diabetes Investigation|November 10, 2018
Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOME® trialTakashi Kadowaki, Masaomi Nangaku, Stefan Hantel, et al.
Pageof 76